Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Lleida (195)

2024

  1. Association between adherence to the mediterranean diet, physical activity, and sleep apnea-hypopnea syndrome (SAHS) in a middle-aged population with cardiovascular risk: Insights from the ILERVAS cohort

    Sleep Medicine, Vol. 116, pp. 19-26

  2. Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?

    Pharmaceuticals, Vol. 17, Núm. 4

  3. Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer’s disease

    GeroScience, Vol. 46, Núm. 1, pp. 683-696

  4. Effects of Vortioxetine on Cognition and Fatigue in Patients with Multiple Sclerosis and Depression: A Case Series Study

    CNS & neurological disorders drug targets, Vol. 23, Núm. 3, pp. 395-401

  5. High-Fat Diet-Induced Obesity Increases Brain Mitochondrial Complex I and Lipoxidation-Derived Protein Damage

    Antioxidants, Vol. 13, Núm. 2

  6. Human lifespan and sex-specific patterns of resilience to disease: a retrospective population-wide cohort study

    BMC Medicine, Vol. 22, Núm. 1

  7. Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men

    Metabolism: Clinical and Experimental, Vol. 157

  8. Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach

    Cell death & disease, Vol. 15, Núm. 2, pp. 127

  9. The shift in the fatty acid composition of the circulating lipidome in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3322-3333

2023

  1. Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial

    Nutrients, Vol. 15, Núm. 17

  2. Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs

    JAMA Neurology, Vol. 80, Núm. 4, pp. 397-403

  3. Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

    Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 134

  4. Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1728-1738

  5. Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study

    Atherosclerosis, Vol. 375, pp. 75-83

  6. Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease

    Antioxidants, Vol. 12, Núm. 2

  7. Gut microbiota links to serum ferritin and cognition

    Gut microbes, Vol. 15, Núm. 2, pp. 2290318

  8. Introduction to special issue on ‘physiological and evolutionary mechanisms of aging’

    Experimental Gerontology

  9. Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project

    Nutrients, Vol. 15, Núm. 1

  10. Lipid Adaptations against Oxidative Challenge in the Healthy Adult Human Brain

    Antioxidants, Vol. 12, Núm. 1

  11. Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1887-1916